PMA Supplement Guidelines At Last, But Industry Might Not Be Satisfied
This article was originally published in The Gray Sheet
Executive Summary
FDA issued a long-awaited PMA supplement decision-making draft guidance March 9, sparking a round of applause from industry members attending AdvaMed's annual meeting in Chandler, Arizona